Christophe Arbet-Engels, M.D., Ph.D.

Christophe Arbet-Engels, M.D., Ph.D.

Chief Medical OfficeratAltimmune· In the 2025 proxy

Pay in FY2025Altimmune stock -49.9% the same year

Christophe Arbet-Engels, M.D., Ph.D. was paid $2.3M in FY2025 (Dec). Altimmune stock fell 49.9% that year.

Pay$100 in the stock at the end of FY24 → $50
Pay is from the Summary Compensation Table of each Altimmune proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AltimmunePublic company · 1 yr
    • Chief Medical Officer2025 – Present · 1 yrStock in role -72%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?